Literature DB >> 20501116

The regional distribution of dopamine and serotonin uptake and transmitter concentrations in the human brain.

J A Hardy1, P Wester, I Backstrom, J Gottfries, L Oreland, A Stenstrom, B Winblad.   

Abstract

The regional distribution of the dopamine and serotonin uptake sites in human brain have been assessed and compared with the distribution of the transmitters and their metabolites measured in the same brains and also with a limited regional distribution of the uptake sites in rat and sheep brain. The affinity of the uptake sites for both transmitters was determined and found to be c. 0.2 ? M in all 3 species. Most dopamine uptake in all species was in caudate and putamen samples. Many regions of the human brain showed no dopamine uptake and little dopamine uptake was seen in sheep cortex or nigral preparations. Dopamine and metabolite concentrations were highest in the caudate, putamen and substantia nigra. Most serotonin uptake was seen in the hypothalamus in all 3 species; less was observed in the striatal regions; the cortical and nigral preparations of sheep brain showed little serotonin uptake though cortical preparations of rat brain had high levels of uptake. In the human brain, other regions did not show serotonin uptake. Highest concentrations of serotonin were found in the substantia nigra and medulla, intermediate concentrations in the putamen, globus pallidus, hypothalamus, olfactory tubercle and thalamus; very low concentrations of serotonin were found in other regions. The use of the human uptake site for pharmacological studies and as a marker for monoaminergic afferents in human health and disease is discussed.

Entities:  

Year:  1987        PMID: 20501116     DOI: 10.1016/0197-0186(87)90070-2

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  6 in total

1.  The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.

Authors:  H Nissbrandt; G Engberg; E Pileblad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

2.  Postmortem- and cryostability of the potassium-evoked release of [3H]5-hydroxytryptamine from rat cerebral cortical miniprisms.

Authors:  C J Fowler; G Thorell; I Fagervall
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

3.  Regional distribution of monoamines and dopamine D1- and D2-receptors in the striatum of the rat.

Authors:  V A Russell; R Allin; M C Lamm; J J Taljaard
Journal:  Neurochem Res       Date:  1992-04       Impact factor: 3.996

4.  [3H]paroxetine and [3H]citalopram as markers of the human brain 5-HT uptake site: a comparison study.

Authors:  B Arranz; J Marcusson
Journal:  J Neural Transm Gen Sect       Date:  1994

5.  Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

Authors:  M Bergeron; T A Reader; G P Layrargues; R F Butterworth
Journal:  Neurochem Res       Date:  1989-09       Impact factor: 3.996

6.  Elucidation of the interplay between Fe(II), Fe(III), and dopamine with relevance to iron solubilization and reactive oxygen species generation by catecholamines.

Authors:  Yingying Sun; A Ninh Pham; T David Waite
Journal:  J Neurochem       Date:  2016-05-12       Impact factor: 5.372

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.